Dr. Todd McDevitt’s research focuses on engineering technologies that direct the differentiation and morphogenesis of stem cells into functional tissue constructs. He is working to create human tissue models that can be used to study development and new approaches to treat multiple diseases that afflict the cardiovascular, neurological, immunological, and musculoskeletal systems.
Dr. McDevitt has received several awards, including a New Investigator Award from the American Heart Association (2004) and the Society for Biomaterials Young Investigator Award (2010). He was also recognized as one of the “40 Under 40” by Georgia Trend magazine (2013) and was inducted in the American Institute of Medical and Biological Engineering (AIMBE) College of Fellows (2014).
Dr. McDevitt graduated with a bachelor’s degree in Biomedical and Electrical Engineering from Duke University. He earned a doctorate in Bioengineering from the University of Washington, where he worked on methods to engineer cardiac and skeletal muscle tissue. He then completed a postdoctoral fellowship in the Department of Pathology at the University of Washington, in which he studied signaling pathways that affect the proliferation of cardiomyocytes derived from pluripotent stem cells.
Gladstone pioneers and consistently produces high-caliber science. Its leadership has forward-thinking vision, and its investigators and researchers foster outstanding science and a collaborative spirit throughout the Institutes. Gladstone has a broad spectrum of research—cellular reprogramming technologies, developmental biology, chemical biology, genome editing—that really complements what my laboratory is doing and will facilitate natural research synergies and collaborations with investigators throughout the Institutes.